At Melorix Medical, Inc., our mission is to revolutionize the field of small vessel anastomosis. Through technologies such as our patented LymphoLock, we are dedicated to developing innovative devices that enhance the safety, reliability, and ease of use in treating diseases affecting the lymphatic system. 

Programs
→ Evolve Venture Accelerator, Northeastern University [2026]
→ MIT linQ IDEA², Massachusetts Institute of Technology, Institute of Medical Engineering & Science (IMES) [2026]
→ Purdue Innovates Firestarter Program, Purdue University [2025]
→ MESH Core Healthcare Innovation Bootcamp, Mass General Brigham [2025]

Melorix Medical™

Org chart

Teams

Offices